Statement Of Cash Flows [Abstract]

PureTech Health plc - Filing #2024169

Concept 2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Interest paid, classified as operating activities
1,701,000 USD
3,366,000 USD
3,382,000 USD
Interest received, classified as operating activities
14,454,000 USD
3,460,000 USD
214,000 USD
Income taxes paid (refund), classified as operating activities
150,000 USD
20,696,000 USD
27,766,000 USD
Other inflows (outflows) of cash, classified as operating activities
1,374,000 USD
359,000 USD
103,000 USD
Cash flows from (used in) operating activities
105,917,000 USD
178,792,000 USD
158,274,000 USD
Cash flows from (used in) investing activities [abstract]
Other cash receipts from sales of equity or debt instruments of other entities, classified as investing activities
33,309,000 USD
118,710,000 USD
218,125,000 USD
Other cash payments to acquire equity or debt instruments of other entities, classified as investing activities
USD
5,000,000 USD
500,000 USD
Proceeds from sales of property, plant and equipment, classified as investing activities
865,000 USD
USD
30,000 USD
Purchase of property, plant and equipment, classified as investing activities
70,000 USD
2,176,000 USD
5,571,000 USD
Purchase of intangible assets, classified as investing activities
175,000 USD
USD
90,000 USD
Cash flows from (used in) investing activities
68,991,000 USD
107,223,000 USD
197,375,000 USD
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
USD
USD
806,000 USD
Payments of lease liabilities, classified as financing activities
3,338,000 USD
4,025,000 USD
3,375,000 USD
Other inflows (outflows) of cash, classified as financing activities
23,000 USD
41,000 USD
5,000 USD
Cash flows from (used in) financing activities
78,141,000 USD
29,827,000 USD
22,727,000 USD
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
41,215,000 USD
315,842,000 USD
61,827,000 USD
Cash and cash equivalents
191,081,000 USD
149,866,000 USD
465,708,000 USD
403,881,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.